Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Healthc Q ; 26(1): 10-13, 2023 Apr.
Article in English | MEDLINE | ID: mdl-37144695

ABSTRACT

Improving access to mental health and substance use (MHSU) services continues to be an area of growing concern in Canada, amplified by the consequences of the COVID-19 pandemic. It was also identified as a priority for federal, provincial and territorial governments in the Shared Health Priorities (SHP) work (CIHI n.d.a.). As part of the SHP work, the Canadian Institute for Health Information recently released 2022 results for two newly developed indicators that help to fill data and information gaps in understanding access to MHSU services in Canada. The first, "Early Intervention for Mental Health and Substance Use among Children and Youth," showed that three in five children and youth (aged 12-24 years) with self-reported early needs accessed at least one community MHSU service in Canada. The second, "Navigation of Mental Health and Substance Use Services," revealed that two out of five Canadians (15 years and older) who accessed at least one MHSU service said that they always or usually had support navigating their services.


Subject(s)
COVID-19 , Mental Disorders , Substance-Related Disorders , Adolescent , Child , Humans , Mental Health , Mental Disorders/epidemiology , Mental Disorders/therapy , Canada/epidemiology , Pandemics , COVID-19/epidemiology , Substance-Related Disorders/epidemiology , Substance-Related Disorders/therapy
2.
Healthc Q ; 22(1): 11-13, 2019 Apr.
Article in English | MEDLINE | ID: mdl-31244462

ABSTRACT

The opioid crisis in Canada is a complex issue with devastating consequences for individuals, families and communities. Pan-Canadian data that provide a better understanding of the crisis are a high priority to help guide efforts for reducing opioid-related harms. The objective of this study is to summarize recent trends of opioid-related harms and opioid prescribing across Canada. Opioid-related harms examined in this study include opioid poisonings, opioid use disorders, adverse reactions to opioids and infants born with neonatal withdrawal symptoms. Data are reported at the pan-Canadian, provincial and community levels.


Subject(s)
Analgesics, Opioid/administration & dosage , Opioid-Related Disorders/epidemiology , Practice Patterns, Physicians'/trends , Analgesics, Opioid/adverse effects , Canada/epidemiology , Emergency Service, Hospital/trends , Hospitalization/trends , Humans , Infant, Newborn , Neonatal Abstinence Syndrome/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...